Lactoferrin- and Dendrimer-Bearing Gold Nanocages for Stimulus-Free DNA Delivery to Prostate Cancer Cells

BACKGROUND: The use of gene therapy to treat prostate cancer is hampered by the lack of effective nanocarriers that can selectively deliver therapeutic genes to cancer cells. To overcome this, we hypothesize that conjugating lactoferrin, a tumor-targeting ligand, and the diaminobutyric polypropyleni...

Descripción completa

Detalles Bibliográficos
Autores principales: Almowalad, Jamal, Laskar, Partha, Somani, Sukrut, Meewan, Jitkasem, Tate, Rothwelle J, Dufès, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968073/
https://www.ncbi.nlm.nih.gov/pubmed/35369035
http://dx.doi.org/10.2147/IJN.S347574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968073/
https://www.ncbi.nlm.nih.gov/pubmed/35369035
http://dx.doi.org/10.2147/IJN.S347574

Ejemplares similares